Dr. Eva Ehlich

"Eva Ehlich is a brilliant, highly experienced and dedicated attorney combining an impressive degree of long-sightedness with exceptional attention to the countless details of a case. She gets great results and is also a nice person to work with."

– IAM Patent 1000, 2023

“An extremely safe pair of hands for complex IP issues and top-level portfolio strategy in the pharmaceutical and biotechnology space, Eva Ehlich is commercially and culturally astute and easily grapples with the complexities and politics of larger international projects.”

– IAM 300, 2022

"Eva Ehlich: Excellent knowledge of the industry; years of experience; excellent strategic thinking; holistic approach."

– Legal 500 DE, 2022

„valuable input regarding FTOs, prosecution and oppositions” (client)

– JUVE Patent, 2021

"The small molecule and biologics know-how of chemist Eva Ehlich is highly prized by pharmaceutical companies across Europe, the United States and Japan."

– IAM Patent 1000, 2021

"Eva Ehlich is another wise choice for international briefs – her focus is on advising innovative US and Japanese pharmaceutical companies on filing strategies and worldwide portfolio management."

– IAM Patent 1000, 2020

"Eva Ehlich zeichnet sich durch ihre seltene Fähigkeit aus, Gründlichkeit mit Pragmatismus zu verbinden. Sie erzielt exzellente Ergebnisse."

– Legal 500 DE, 2020

“Eva Ehlich is a master of European patent strategy and consistently provides brilliant advice that advances clients’ IP and business objectives.” She is a fan favourite when it comes to IP commercialisation.”

– IAM Strategy 300, 2023